HK1178886A1 - Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring - Google Patents
Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ringInfo
- Publication number
- HK1178886A1 HK1178886A1 HK13105592.6A HK13105592A HK1178886A1 HK 1178886 A1 HK1178886 A1 HK 1178886A1 HK 13105592 A HK13105592 A HK 13105592A HK 1178886 A1 HK1178886 A1 HK 1178886A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- carboxylic acid
- acid derivatives
- heterocyclic carboxylic
- oxazolopyrimidine ring
- substituted oxazolopyrimidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10305043 | 2010-01-14 | ||
PCT/EP2011/050302 WO2011086080A1 (de) | 2010-01-14 | 2011-01-12 | Heterocyclische carbonsäurederivate mit einem 2,5-substituierten oxazolopyrimidinring |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1178886A1 true HK1178886A1 (en) | 2013-09-19 |
Family
ID=41820700
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK13105592.6A HK1178886A1 (en) | 2010-01-14 | 2013-05-10 | Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring |
Country Status (21)
Country | Link |
---|---|
US (1) | US8846690B2 (es) |
EP (1) | EP2523960B1 (es) |
JP (1) | JP5841068B2 (es) |
KR (1) | KR101759127B1 (es) |
CN (1) | CN102834399B (es) |
AR (1) | AR079884A1 (es) |
AU (1) | AU2011206616B2 (es) |
BR (1) | BR112012017447B1 (es) |
CA (1) | CA2804128C (es) |
DK (1) | DK2523960T3 (es) |
ES (1) | ES2437471T3 (es) |
HK (1) | HK1178886A1 (es) |
IL (1) | IL220718A (es) |
MX (1) | MX2012007836A (es) |
MY (1) | MY156476A (es) |
PT (1) | PT2523960E (es) |
RU (1) | RU2559896C2 (es) |
SG (1) | SG182474A1 (es) |
TW (1) | TWI482623B (es) |
UY (1) | UY33180A (es) |
WO (1) | WO2011086080A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY33177A (es) | 2010-01-13 | 2011-08-31 | Sanofi Aventis | Derivados de ácido carboxílico que comprenden un anillo de oxazolopirimidina 2, 5, 7-sustituido |
TWI485153B (zh) | 2010-01-13 | 2015-05-21 | Sanofi Aventis | 2,5,7-經取代唑并嘧啶衍生物 |
CN102791717B (zh) * | 2010-01-14 | 2016-03-30 | 赛诺菲 | 具有2,5-取代的噁唑并嘧啶环的羧酸衍生物 |
JP5841069B2 (ja) | 2010-01-14 | 2016-01-06 | サノフイ | 2,5−置換されたオキサゾロピリミジン誘導体 |
US9309019B2 (en) | 2010-05-21 | 2016-04-12 | Adhezion Biomedical, Llc | Low dose gamma sterilization of liquid adhesives |
US9321787B2 (en) | 2011-07-07 | 2016-04-26 | Sanofi | Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3679682A (en) * | 1970-04-23 | 1972-07-25 | Fmc Corp | CERTAIN 5H-ISOXAZOLO{8 5,4-d{9 PYRIMIDIN-4-ONES |
EP1622866B1 (en) * | 2003-04-30 | 2012-07-25 | Novartis AG | Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators |
BRPI0410454A (pt) * | 2003-05-19 | 2006-06-13 | Irm Llc | composições e compostos imunossupressores |
AR044402A1 (es) * | 2003-05-19 | 2005-09-14 | Irm Llc | Compuestos heterociclicos y su uso como inmunodepresores. composiciones farmaceuticas que los contienen. |
CA2619101A1 (en) * | 2005-08-23 | 2007-03-01 | Irm Llc | Immunosuppressant compounds and compositions |
WO2007061458A2 (en) * | 2005-11-23 | 2007-05-31 | Epix Delaware, Inc. | S1p receptor modulating compounds and use thereof |
WO2007109334A2 (en) * | 2006-03-21 | 2007-09-27 | Epix Delaware, Inc. | Sip receptor modulating compounds and use thereof |
TW201000099A (en) * | 2008-06-20 | 2010-01-01 | Amgen Inc | S1P1 receptor agonists and use thereof |
RU2503680C2 (ru) * | 2008-07-15 | 2014-01-10 | Санофи-Авентис | ОКСАЗОЛОПИРИМИДИНЫ КАК АГОНИСТЫ РЕЦЕПТОРА Edg-1 |
TWI485153B (zh) * | 2010-01-13 | 2015-05-21 | Sanofi Aventis | 2,5,7-經取代唑并嘧啶衍生物 |
UY33177A (es) * | 2010-01-13 | 2011-08-31 | Sanofi Aventis | Derivados de ácido carboxílico que comprenden un anillo de oxazolopirimidina 2, 5, 7-sustituido |
AR079982A1 (es) * | 2010-01-13 | 2012-03-07 | Sanofi Aventis | Derivados de acido carboxilico heterociclicos que comprenden un anillo de oxazolopirimidina 2,5,7- sustituido., composiciones farmaceuticas y procesos para prepararlos. |
CN102791717B (zh) * | 2010-01-14 | 2016-03-30 | 赛诺菲 | 具有2,5-取代的噁唑并嘧啶环的羧酸衍生物 |
JP5841069B2 (ja) * | 2010-01-14 | 2016-01-06 | サノフイ | 2,5−置換されたオキサゾロピリミジン誘導体 |
-
2011
- 2011-01-12 PT PT117003392T patent/PT2523960E/pt unknown
- 2011-01-12 SG SG2012051173A patent/SG182474A1/en unknown
- 2011-01-12 JP JP2012548411A patent/JP5841068B2/ja active Active
- 2011-01-12 AU AU2011206616A patent/AU2011206616B2/en not_active Ceased
- 2011-01-12 ES ES11700339.2T patent/ES2437471T3/es active Active
- 2011-01-12 CN CN201180013920.1A patent/CN102834399B/zh active Active
- 2011-01-12 AR ARP110100093A patent/AR079884A1/es active IP Right Grant
- 2011-01-12 EP EP11700339.2A patent/EP2523960B1/de active Active
- 2011-01-12 WO PCT/EP2011/050302 patent/WO2011086080A1/de active Application Filing
- 2011-01-12 TW TW100101052A patent/TWI482623B/zh not_active IP Right Cessation
- 2011-01-12 CA CA2804128A patent/CA2804128C/en not_active Expired - Fee Related
- 2011-01-12 MY MYPI2012002623A patent/MY156476A/en unknown
- 2011-01-12 BR BR112012017447-9A patent/BR112012017447B1/pt not_active IP Right Cessation
- 2011-01-12 UY UY0001033180A patent/UY33180A/es not_active Application Discontinuation
- 2011-01-12 DK DK11700339.2T patent/DK2523960T3/da active
- 2011-01-12 MX MX2012007836A patent/MX2012007836A/es active IP Right Grant
- 2011-01-12 US US13/521,828 patent/US8846690B2/en active Active
- 2011-01-12 RU RU2012134548/04A patent/RU2559896C2/ru active
- 2011-01-12 KR KR1020127021241A patent/KR101759127B1/ko active IP Right Grant
-
2012
- 2012-07-02 IL IL220718A patent/IL220718A/en active IP Right Grant
-
2013
- 2013-05-10 HK HK13105592.6A patent/HK1178886A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BR112012017447A2 (pt) | 2016-04-19 |
SG182474A1 (en) | 2012-08-30 |
US20130072502A1 (en) | 2013-03-21 |
MX2012007836A (es) | 2012-07-30 |
RU2559896C2 (ru) | 2015-08-20 |
IL220718A (en) | 2015-02-26 |
CN102834399A (zh) | 2012-12-19 |
RU2012134548A (ru) | 2014-02-20 |
US8846690B2 (en) | 2014-09-30 |
EP2523960A1 (de) | 2012-11-21 |
TW201134474A (en) | 2011-10-16 |
KR20120101731A (ko) | 2012-09-14 |
DK2523960T3 (da) | 2014-01-20 |
CN102834399B (zh) | 2015-04-22 |
PT2523960E (pt) | 2013-12-09 |
JP5841068B2 (ja) | 2016-01-06 |
BR112012017447B1 (pt) | 2019-10-29 |
KR101759127B1 (ko) | 2017-07-18 |
MY156476A (en) | 2016-02-26 |
AR079884A1 (es) | 2012-02-29 |
CA2804128A1 (en) | 2011-07-21 |
EP2523960B1 (de) | 2013-10-16 |
JP2013517242A (ja) | 2013-05-16 |
WO2011086080A1 (de) | 2011-07-21 |
AU2011206616B2 (en) | 2016-06-16 |
UY33180A (es) | 2011-08-31 |
TWI482623B (zh) | 2015-05-01 |
ES2437471T3 (es) | 2014-01-10 |
AU2011206616A1 (en) | 2012-08-02 |
CA2804128C (en) | 2017-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201206440B (en) | [5,6]heterocyclic compound | |
HK1187606A1 (zh) | 取代的 -稠合含氮雜環化合物及其用途 | |
ZA201205788B (en) | 1,2,4-triazine-4-amine derivatives | |
IL225770A0 (en) | Heterocyclic compounds | |
IL221442A0 (en) | Heterocyclic compound | |
ZA201300950B (en) | Heterocyclic compound | |
PL2521450T3 (pl) | Grzybobójcze związki heterocykliczne | |
AP2010005364A0 (en) | Novel heterocyclic compounds. | |
AP3589A (en) | A novel 1,2,3,4-tetrahydroquinoline derivative useful for the treatment of diabetes | |
HK1198535A1 (en) | 5-(3-aminophenyl)-5-alkyl-5,6-dihydro-2h-[1,4] oxazin-3-amine derivatives 5-(3-)-5--5,6--2h-[1,4]-3- | |
HK1178886A1 (en) | Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring | |
HK1178885A1 (en) | Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring | |
EP2459573A4 (en) | SUBSTITUTED 1,2-AZABORIN HETEROCYCLES | |
IL229712A (en) | The aryl sulfonamide compounds are converted into two positions 2 and 5 | |
HK1180314A1 (en) | Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring 257- | |
IL220707A0 (en) | 2,5,7-substituted oxazolopyrimidine derivatives | |
EP2583965A4 (en) | HETEROCYCLIC RING CONNECTION | |
HK1178888A1 (en) | Heterocyclic carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring | |
EP2632255A4 (en) | HETEROCYCLIC DIAZENIUM DIOLATE DERIVATIVES | |
IL214110A0 (en) | 2,3-diaryl-or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds | |
HK1178887A1 (en) | 2,5-substituted oxazolopyrimidine derivatives as edg-1 agonists edg-1 25- | |
HK1162032A1 (en) | 1,1,1-trifluoro-2-hydroxypropyl compounds 111--2- | |
GB201021416D0 (en) | Novel heterocyclic compounds | |
GB201009514D0 (en) | Novel heterocyclic compounds | |
GB0919817D0 (en) | Heterocyclic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20220108 |